Lehigh Center for Clinical Research LLC

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Depression2 trials
• Alzheimer disease1 trial
• Bipolar disorder1 trial

Phase

• Phase 33 trials
• Phase 22 trials
• Phase 2/31 trial

Status

• Completed3 trials
• Terminated2 trials
• Recruiting1 trial

Lead sponsor

• Biogen1 trial
• Denovo Biopharma LLC1 trial
• Intra-Cellular Therapies, Inc.1 trial
• Janssen Research & Development, LLC1 trial
• Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial
• and 1 more

Running trials

• Recruiting

  Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder

  NCT06480383· Phase 2· Intra-Cellular Therapies, Inc.· Source

Closed trials

• Completed

  A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

  NCT05729373· Phase 2/3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Completed

  A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

  NCT05550532· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD

  NCT05113771· Phase 2· Denovo Biopharma LLC· Source

• Terminated

  A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).

  NCT05227209· Phase 3· Sumitomo Pharma America, Inc.· Source

• Terminated

  A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

  NCT04241068· Phase 3· Biogen· Source